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Is it time for a new approach in cardiovascular
risk assessment?
FROM CONVENTIONAL RISK FACTORS TO THE
CLUSTERING OF VARIOUS FACTORS
Prospective epidemiologic studies have established risk factors foratherosclerotic cardiovascular diseases, including: advanced age,
smoking, obesity, diabetes or glucose intolerance, elevated blood lipids,
hypertension and sedentary life habits. Many of these factors are closely
related to modern lifestyles and can be modified. They have been used
for the risk estimation and the planning of preventive measures (1, 2).
In addition to the commonly used classic risk factors, there is evidence
suggesting the existence of novel risk factors, including: inflammation,
chronic latent infections e.g. cytomegalovirus or Helicobacter pylori in-
fection, hypercoagulability, impaired fibrinolysis, increased platelet re-
activity, enhanced oxydative stress, elevated blood homocysteine levels
and lipoprotein particles such as lipoprotein (a) and small dense low-
density lipoprotein cholesterol (3). Depression and complex socioeco-
nomic factors have also been recognized as factors strongly influencing
the prognosis in cardiovascular diseases (3, 4). These novel factors might
be useful in stratifying cardiovascular disease severity and prognosis
more accurately. This may be important especially in cases free of
conventional risk factors, as it has been shown that up to one third of
first coronary events occur among individuals without conventional
risk factors (5). In addition, the same risk factors may not have the same
causal effect in different ethnic and population groups (6).
Moreover, there is an awareness of the fact that risk factors tend to
appear in a cluster, linked to each other. For example, the metabolic or
insulin resistance syndrome has been identified on the basis of the
clustering of multiple cardiovascular risk factors (7). Similarly, end-
stage renal disease has been recognized as a multirisk condition, cha-
racterized by an unexpectedly high prevalence of cardiovascular di-
seases (8).
Taking all these into consideration, it is not surprising that the pre-
paration of cardiovascular risk estimation tables and guidelines be-
comes more and more difficult (9). Two opposite, but also complemen-
tary claims can be observed: a need for a more comprehensive and, at
the same time, a more individually based approach in cardiovascular
risk assessment. In particular, the problem is how to interpret the re-
sults of the basic research and clinical and epidemiologic studies to be
specifically oriented towards conditions of an individual. Evidence from
many fields of research indicates that it is time for a new approach in
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Viewpoint
THE HUMAN GENOME PROJECT,
GENOMICS, PROTEOMICS,
PERSONALISED MEDICINE
The most important question regarding prevention in
cardiovascular diseases is how to determine to what ex-
tent they are inheritable and to what extent environ-
mental factors contribute to their expression (10). The
recent breakthrough in the Human Genome Project,
tightly linked to the progress in molecular biology tech-
niques, has been expected to provide insight into the
genetic background of cardiovascular and other complex
common diseases (11). However, high expectations were
replaced by overwhelming skepticism about the near-
term applications of genomics in health care and com-
mon disease prevention (12). Gene profiling assays so far
have not provided benefits in cardiovascular risk predic-
tion beyond the current approach, by using conventional
risk factors (10, 11, 12, 13). It has been shown that there is
no specific disease susceptibility genotype, just numerous
genetic variants which account simultaneously for many
age-related phenotypes. That means that the individual
variant, important in the particular molecular pathway,
is not sufficient to cause clinical expression of a disease.
Instead, common diseases in the population result from
the complex interactions among multiple genetic variants
and environmental risk factors. Thus, genetic and envi-
ronmental factors are shared between clinically related
disorders (13).
Yet, a more positive note is that in common disease
prevention, practical application of genomics is going to
assume more realistic dimensions. Genetic information
is now used only in addition to public health interven-
tions, not as the task of the priority. This is because the
major environmental factors, known to influence the fre-
quency of common diseases and the mortality rate in the
population, such as: cigarette smoking, unhealthy diet,
physical inactivity, excessive alcohol use, infections, inju-
ries and exposure to toxins, were proved to be to a great
degree modifible. To assess whether interventions based
on genetics might add value in disease prevention to the
existing approach, by implementing public health mea-
sures, information is required on: the prevalence of high-
risk genetic variants in the given population, the strength
of the association between these variants and a disease of
interest by means of a population perspective, and modi-
fication of risk by other genetic and environmental fac-
tors (12).
Personalised medicine continues to be the desired goal
of health care in general and, in particular, of preventive
medicine (14). Realization of this idea is closely related to
the problem of conversion from basic science to clinical
applications. Advances in genomics and proteomics give
promise that it could be possible to cover the distance
from discovering new knowledge to provide better health
care to individuals and to the population as a whole (12,
14). The greatest effects are expected in personalised
nutrition, specifically aimed at maintaining the health of
an individual and prevention of diseases, as well as in
customizing therapy, by maximizing the effectiveness of
drugs and minimizing their side effects. The challenges
also lie in the detection of persons with early deviations,
long before biochemical and clinical signs of a disease
become clearly measurable (14, 15). In addition, the
availability of computer programs in practical application
in medicine is expected to allow the choice of such diag-
nostic and therapeutic protocols which could meet the
specific needs of an individual with the priorities. Ac-
complishing the goal of personalised medicine will also
require systematic knowledge integration and transdisci-
plinary collaboration, as well as efforts in the develop-
ment of a health care policy and services (12, 14, 16).
COMMON BACKGROUND FOR
ATHEROSCLEROSIS AND OTHER AGING
DISORDERS, AGING THEORIES
Two lines of evidence, one showing atherosclerosis as
an inflammatory disease and the other indicating chro-
nic inflammation as the main driving force underlying
the processes of aging, seem to converge into one unique
concept, putting atherosclerosis into the same pathoge-
netic background with other common aging disorders.
Atherosclerosis was first considered a lipid-storage
arterial disease. Subsequently, it has been established as a
chronic inflammatory disease. In particular, the role of
innate immunity has been confirmed equally in all stages
of plaque development, from initiation, progression, to
thrombotic complications (17, 18). Also, it has been found
that low-grade inflammation, indicated by increased serum
levels of C-reactive protein (CRP) and interleukin-6 (IL-6),
may predict the risk of acute myocardial infarction inde-
pendently of traditional risk factors (19, 20). Besides
inflammatory mediators produced locally, within the af-
fected vascular wall, the production of mediators at other
sites of infection and inflammation in the body, if releas-
ed in the circulation, may contribute to the progression of
atherosclerosis (21). Furthermore, recent studies on ge-
netics provide evidence that testing on the polymor-
phism of proinflammatory genes may add information
to the cardiovascular risk profile. Included genes are
those coding for: proinflammatory cytokines (TNF-a,
IL-1 and IL-6), toll-like receptors, known to initiate the
innate immune response to bacterial lipopolysaccharide,
and lipid mediators cyclooxygenase-1 and -2 and lipo-
oxygenase-5 (10, 21, 22).
Numerous aging theories have been constructed, in-
dicating the complex and largely unknown process of
aging. Former theories were monistic in nature, assum-
ing one key factor responsible for the aging. They can
generally be classified in two categories: program theo-
ries and error (mutation) theories. According to program
theories, aging is considered as a genetically determined
process. The error theories imply the accumulation of the
deleterious changes in cells and tissues, leading to muta-
tions, regulation disorders and clinically obvious dysfunc-
tions (23). New theories, in contrast, are multifactorial
and tend to reflect the complex and highly integrated
nature of the human body (21, 23). Thus, according to
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»the network theory of aging«, aging is controlled by the
network of cellular and molecular defense mechanisms,
involving: DNA repair mechanisms, heat shock protein
production, anti-oxidant system, apoptosis, cell senescence,
scavenging of damaged cells and replacement of dead
cells by stem cells. At the systems level, mechanisms of
control are represented by immune and inflammatory
responses, stress response and neuroendocrine responses
(24). A major assumption of this theory is that the vari-
able longevity of individuals in the population can be
explained by subtle differences in the efficiency of their
network of defense mechanisms. Based on this assump-
tion, many age-related changes of the immune parame-
ters could be explained as a result of an adaptation of the
immune system, with time, to the deteriorative environ-
mental agents (the process termed »immunosenescen-
ce«) (25). Following a similar assumption, age-related
changes in metabolic pathways and in endocrine func-
tions, especially those concerning the hypothalamus-pi-
tuitary-adrenal (HPA) stress axis, were also explained as
the time-dependent remodelling process (the paradigm
named »the remodelling theory of aging«) (24, 26).
Evidence suggests that these three systems, the im-
mune, the metabolic and the endocrine, are connected
and capable of influencing each other during the age-de-
pendent remodelling (21, 26, 27, 28). Chronic inflamma-
tion has been recognized as that mechanism which links
changes in these systems together, leading to the de-
velopment of the main aging diseases, including: athero-
sclerosis, cancer, Alzheimer`s disease, diabetes, osteopo-
rosis and osteoarthritis (21, 29). In favor of such an
assumption, factors previously already found to contri-
bute to the state of chronic inflammation are: insulin
resistance and central body fat distribution (reflecting the
remodelling of the metabolic pathways), decreased pro-
duction of sex steroids and the HPA stress axis over-acti-
vation (due to the remodelling of the neuroendocrine
system), existing sites of chronic inflammation (such as
atherosclerotic vessels) and the chronic activation of the
innate immune system (due to immunosenescence). In
addition, the genetically determined capacity of inflam-
matory mediator production and, reversely, the capacity
of anti-inflammatory (defence) network, might contri-
bute to the fine tuning of the inflammatory responses
(21, 29).
Epigenetic regulation of gene
expression, intrinsic and environmental
signals, intra-individial variability,
self-sustaining (stochastic) nature of
aging mechanisms
An important assumption emerges from the compre-
hensive theories of aging, mentioned above. That is,
inflammation and other age-related changes of cell mi-
croenvironment can cause changes in gene expression
and proteome profiling in the local tissue environment
(29). There is evidence suggesting that chemicals, pro-
duced during metabolic and inflammatory processes,
e.g. reactive oxygen species, may interfere with »normal«
DNA transcriptional and repair processes and with in-
tra- and inter-cellular signaling (27, 30, 31).
Two important consequences may result from this
assumption. One is the fact that inner physiological per-
turbations, by themselves, can be included in regulation
processes. This may further imply the self-sustaining,
stochastic nature of the aging mechanisms (31). In favour
of this, efforts over the past few years have been focused
on molecular mechanisms that mediate epigenetic me-
chanisms of control of gene expression. As a potentially
most important mechanism, change in DNA methyla-
tion has been proposed (32). This mechanism, arising
from the age-related disturbation in certain nutritional
and cellular metabolic pathways, seems to be capable of
promoting genetic changes in somatic cells. This may
initiate a sequence of reactions, leading step by step to
the development of cancer and other aging diseases (32,
33). In addition, it is supposed that epigenetic mecha-
nisms of the control of gene activity represent the main
way through which an organism responds to external
environmental signals. In this way, it is difficult to strongly
divide intrinsic and environmental signals (32).
Another important consequence of locally mediated
changes in gene expression and proteome profiling, emerg-
ing from this discussion, is the difference in the rate of
aging among different organs and systems of the body.
This phenomenon really accompanies aging and is term-
ed »the intra-individual variability« (34). Based on these
facts, the study of aging is connected with substantial
difficulties.
Population statistics, mortality curves,
inter-individual variability, complex
systems
For the purpose of vital statistics data recording, the
monotonic hazard functions are usually employed, de-
scribing the age dependence of mortality (35, 36, 37).
This type of approach can also be used to gain insights
into the link between the aging processes and mortality.
According to Gompertz' law, the most widely used theo-
retical model of mortality kinetics, progressive deterio-
ration in the vitality (an overall index of physiologic
capacity) is proposed. However, this model does not fit
the empirical data in all applications. Exactly, discre-
pancy appears when data of people in advanced age are
considered, reflecting inter-individual differences in the
age-dependent risk of death. In such a situation, the end
of the mortality curve begins a slow, downward direction
instead of continuing its positive exponential course,
reflecting the positive selection of living longer, more
healthy individuals and the exhaustion of high-risk sub-
groups. In general, data concerning heterogeneity must
be included in any model aimed at interpreting the link
between aging and mortality correctly. It is supposed that
the variability of biological parameters, among indivi-
duals of the population, visible especially in the elderly,
can be a result of a dynamic interplay between biological
factors and the environment. However, results of studies on
laboratory-housing animals suggest that it is impossible
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to eliminate heterogeneity completely, even in the case of
extremely homogeneous conditions, regarding both ge-
netical and environmental factors. In order to find an
appropriate description of this phenomenon, an entirely
new approach in the research of aging was entered (35,
36, 37).
Thus, if human beings are considered as nonlinear
complex systems, their age-related changes can easily be
explained from that point of view. This means that even
small differences among subjects at the time of birth will
evolve, fluctuating with time, progressively enlarging the
variability of their characteristics, including life-span
(31, 35, 36, 38, 39). This may be a result of the fundamen-
tal property of complex systems, known as »dependency
on the starting conditions« (38, 39). Other major features
of complex systems which may contribute to a large di-
versity of aging phenotypes include their relative stability
on minor changes in the environment, but great instabil-
ity in the case of larger shocks, resulting in many ways in
which the response can be manifested (35, 38, 39). The
principle of »locality«, another major feature of complex
systems, means a process composed of a variety of strictly
spatially organized mechanisms of cell-cell interactions,
taking place locally, in tissues. This may be a basis for the
intra-individual variability, described in the previous
chapter (31, 38).
In addition, complex systems show characteristics of
an »emergent behavior«, meaning that a global behavior
of the system as a whole cannot be understood on the
basis of the knowledge of the behavior of its particular
components (31, 35, 38, 39). Such approach allows new
strategies to be used in building mathematical models of
aging, those from the perspective of systems biology sci-
ence (31, 40, 41). To find out the ways components of the
system are linked to each other, forming functionally
integrated units, a relatively large number of parameters
will be required. The challenge will be to develop such
mathematical models which will be able to integrate
numerous concepts on aging into a unique model (31).
Attempts to study aging from the perspective of complex
systems have already been done. In particular, findings
are available suggesting a decrease of complexity with
age (42). These findings give the hope that, by studying
aging from the point of view of complex systems, sub-
stantial new contributions could be obtained.
Aging and systems biology,
bioinformatics, decision making
processes in health care
Current theories of aging, mentioned above, empha-
size aging as complex traits resulting from the interaction
of genetics, environment and stochasticity. It is now ob-
vious that there is a need for more comprehensive, sys-
tems approaches in studying aging. Therefore, studing
humans is more advantageous than previous studies,
prepared on animal models, owing to the high complexity
of the human body. In particular, studing humans shows
the benefit due to the influence of the social environ-
ment, dominated by cultural and anthropological habits,
on characteristics of different population groups (29, 31).
A large contribution to the knowledge on aging has been
obtained from comparative studies on centenarians, a
specific population group characterized by healthy aging
and extreme longevity (26, 29, 43).
The relatively old idea of systems biology is now plac-
ed in the field of bioinformatics, linking it to the ability to
collect experimental data on-line (40, 41). The manag-
ing of a large database is proposed when building com-
puter models. To achieve the goal of implementing systems
biology methods in practical medicine, the development
of advanced software and analytical mathematics should
be an ongoing process (31, 40, 41). In addition, a better
understanding of human mental and reasoning proces-
ses will be necessary. Such attempts have been made in
decision making processes in health care. The role of
more humanistic strategies, such as visual cognition,
pattern perception and intuitive processing, has been
addressed (44).
Systems biology approaches allow many unexpected
results and hidden information to be obtained, otherwise
not apparent from traditional approaches, by using phe-
nomenological descriptions of a few data (31). In gene-
ral, computer modelling technics can be divided into two
categories: bottom-up and top-down approaches. The
top-down approach starts with a system as a whole and
disects it into functional and computable entities. A de-
scription of higher levels of biological organization, such
as cells arrangements in tissues and spatial representa-
tion of supply networks, such as the circulatory system
and the bronchial tree of the lung, becomes visible by
using this approach. In this way, fractal properties of
biological structures (self-similarities, or re-occuring of
basic shapes in filling up the space) have been found. Such
spatial organization seems to be maximally space-saving
and optimizing in terms of energy dissipation (31).
In the bottom-up type of modelling, data on basic
entities, such as genes and proteins, are integrated in
order to define patterns in functional (time-scalled) or-
ganization. Methodological tools such as Multivariant
analysis and Data-Mining, an advanced statistical tech-
nique, are required, when trying to generalize funda-
mental knowledge on individual parts and identify the
key pathways and their connections. By using systems
biology approaches, recent advances in human genome
and proteome mapping projects have started to provide
valuable contributions in our understanding of the biol-
ogy of aging. For example, early results confirm certain
topology in gene regulation pathways, meaning that a
few genes have a higher number of connections, than the
rest, and are able to receive and direct the signals of many
genes. These genes, being constantly up- or down –
regulated, seem to be more tightly associated with the
aging process. They are usually involved in cell cycling
and cell signaling, leading to the cellular senescence and
apoptosis (31).
Finally, multiscale, spatio-temporal models have re-
cently been suggested, allowing molecular processes to
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be represented in a line with structural organization.
Such models are expected to cope best with the principles
of aging, as aging phenotypes manifest on a systems
level, but emerging from networked processes, regulated
across different levels of biological organization (31).
Is it time for a new approach in
cardiovascular risk assessment?
It is now obvious that many phenomena in human
pathophysiology, especially those concerning aging, can-
not be explained by studying the impact of a single
variable, or even a few of them. Because of many limi-
tation of the reductionistic approach, still widely used in
dealing with medical problems, the systems biology ap-
proach has got the chance to emerge. An increasing
interest in the systems theory approach is also linked to
the progress of science in many fields and advances in
computer technology and applications as well. All neces-
sary preconditions for its wider implementation in medi-
cine have not yet been achieved. Scientists, engaged in
aging research, emphasize two main obstacles in trying
to study aging phenomena from the perspective of the
systems-level approach. These are: an insufficient know-
ledge about determinants of the aging process and, con-
sequently, the lack of standardized biomarkers of aging
(36, 37).
We assume that terms such as »biomarkers«, or »deter-
minants«, represent elements of the reductionistic way of
thinking, which sustains our sense of »cause and effect«
when dealing with biological phenomena (38, 39, 41).
Therefore, it is most important that we change our way
of thinking. We should direct our interests towards the
behavior of the whole system, by pointing out typical
»patterns of disorders« and their changes with time (31,
38, 39) (Figure 1, 2). Advanced »software« will be crucial
in achieving this aim, allowing the management of a
large set of data. Data of different types, both descriptional
and numerical, clinical, biochemical, or those obtained
by sophisticated laboratory technics, could be of interest.
Mathematical models cannot incorporate all data avail-
able. Instead, computer modelling has to be directed on
selected properties of the pathophysiologic process under
investigation. By using »Data-Mining«, or some other
advanced analytical technics, it will be possible to achie-
ve »natural« clustering of data to become visible. Use of
prior knowledge will be necessary, to complement pure
statistical and clustering techniques (31).
In order to make predictions about future adverse
cardiovascular events, computerized patient record systems
have to be employed, to allow collecting data prospecti-
vely. We suggest the methodology of defining »patterns of
disorders«, in the population of interest, in relation to
years of prediction (Figure 2). Even when considering a
huge heterogeneity among individuals in the popula-
tion, the definition of such patterns seems to be possible,
as complex systems show an ability to occupy only a
limited number of specific states (38, 39). Conditions of
any individual patient can then be compared with a set of
patterns, previously obtained by computation of data on
the population as a whole. Moreover, an individual risk
could be more accurately fitted by using additional data,
such as data on family history of a disease, subjective
psychological profile, or intentionally designed genetical
tests. The earlier we take the first steps, the faster we can
move on the implementation of the systems biology ap-
proaches in medical practice.
The Data-Mining technic was used to analyse a large
set of data. A cluster of data was obtained and explained
in light of existing knowledge. In this way, a functional
pathway, or »the pattern of disorders«, was constructed.
(A scheme was taken out from our original work on hyper-
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Figure 1. »The pattern of disorders« or »the networked reaction«
Figure 2. Model of prediction of future cardiovascular incident (CV), from the perspective of complex systems science
homocysteinemia. It is visible that some components in the
network are more important, by having more connections,
than others).
A limited number of »patterns of disorders« can be
identified in the population. Changes in patterns, with
time, can be used in cardiovascular risk assessment. By
comparing conditions of an individual with a set of
»patterns«, an individual risk can be estimated.
REFERENCES
1. LERNER D J, KANNEL W B 1986 Patterns of coronary heart
disease morbidity and mortality in the sexes : A 26-year follow-up of
the Framingham population. Am Heart J February: 383–390
2. COOPER J A, MILLER G J, HUMP HRIES S E 2005 A com-
parison of the PROCAM and Fraingham point-scoring systems for
estimation of individual risk of coronary heart disease in the Second
Northwick Park Heart Study. Atherosclerosis 181: 93–100
3. KULLO I J, GAU G T, TAJIK A J 2000 Novel risk factors for
atherosclerosis. Mayo Clinic Proc 75: 369–380
4. ENGSTROM G, JERNTROP I, PESSAH-RASMUSSEN H,
HEDBLAD B, BERGLUND G, JANZON L 2001 Geographic
distribution of stroke incidence within an urban population: rela-
tions to socioeconomic circumstances and prevalence of cardiovas-
cular risk factors. Stroke 32(5): 1098–103
5. HELLER R F, CHINN S, PEDOE H D, ROSE G 1984 How well
can we predict coronary heart disease? Findings in the United
Kingdom Heart Disease Prevention Project. BMJ 288: 1409–1411
6. REDDY K S, YUSUF S 1998 Emerging epidemic of cardiovascular
disease in developing countries. Circulation 97: 596–601
7. MEIGS J B, D'AGOSTINO R B, WILSON P W F, CUPPLES L A,
NATHAN D M, SINGER D E 1997 Risk variable clustering in the
insulin resistance syndrome. Diabetes 46: 1594–1600
8. YOA Q, LINDHOM B, STENVINKEL P 2004 Inflammation as a
cause of malnutrition, atherosclerotic cardiovascular disease, and
poor outcome in hemodialysis patients. Hemodial Int 8: 118–129
9. INTERNATIONAL ATHEROSCLEROSIS SOCIETY 2003 Har-
monized Clinical Guidelines on Prevention of Atherosclerotic Vas-
cular Disease: Executive summary
10. CASAS J P, COOPER J, MILLER G J, HINGORANI A D, HUMP-
HRIES S E 2006 Investigating the genetic determinants of cardio-
vascular disease using candidate genes and meta-analysis of as-
sociation studies. Ann Human Genetics 70: 145–169
11. YANG Q, KHOURY M J, FRIEDMAN J M, LITTLE J, FLAN-
DERS W D 2005. How many genes underlie the occurrence of
common complex diseases in the population. Int J Epidemiol 34(5):
1129–1137
12. KHOURY M J, GWINN M, BURKE W, BOWEN S, ZIMMERN
R 2007 Will genomics widen or help heal the schism between
medicine and public health. Am J Prev Med 33(4): 310–317
13. BECKER K G 2003 The common variants/multiple disease hypo-
thesis of common complex genetic disorders. Medical hypotheses
62(2): 309–317
14. ASPINALL M G, HAMERMESH R G 2007 Realizing the promise
of personalized medicine. Harvard Business Review, October, p
109–117
15. ORDOVAS J M, MOOSER V 2004 Nutrigenomics and nutrige-
netics. Curr Opin Lipidol 15(2): 101–108
16. ZVAROVA J, STUDENY M 1997 Information theoretical approach
to constitutions and reduction of medical data. Int J Med Informatics
45: 65–74
17. WICK G, SCHETT G, AMBERGER A, KLEINDIENST R, XU
Q 1995 In atherosclerosis an immunologically mediated disease.
Immunol Today 16(1): 27–33
18. YOKOTA T, HANSSON G K 1995 Immunological mechanisms in
atherosclerosis. J Int Med 218: 479–489
19. RIDKER P M, RIFAI N, STAMPFER M J, HENNEKENS C H
2000 Plasma concentration of interleukin-6 and the risk of future
myocardial infarction among apparently healthy men. Circulation
18: 1767–1772
20. KULLER L H, TRACY R P, SHATEN J, MEILAHN E N 1996
Relation of C-reactive protein and coronary heart disease in the
MRFIT nested case-control study. Am J Epidemiol 144: 537–47
21. VASTO S, CANDORE G, BALISTRERI C R, CARUSO M, CO-
LONA-ROMANO G, GRIMALDI M P, LISTI F, NUZZO D, LIO
D, CARUSO C 2007 Inflammatory networks in ageing, age-related
diseases and longevity. Mech Age Dev128: 83–91
22. GRIMALDI M P, VASTO S, BALISTRERI C R, DI CARLO D,
CARUSO M, INCALCATWRRA E, LIO D, CARUSO C, CAN-
DORE G 2007 Genetics of inflammation in age-related atheroscle-
rosis. Ann N Y Acad Sci 1100: 123–131
23. SEMSEI I 2000 On the nature of aging. Mech Age Dev117: 93–108
24. FRANCESCHI C, VALENSIN S, BONAFE M, PAOLISSO G,
YASHIN A I, MONTI D, DE BENEDICTIS G 2000 The network
and the remodeling theories of aging: historical background and
new perspectives. Exp Gerontol 35(6–7): 879–896
25. FRANCESCHI C, BONAFE M, VALENSIN S 2000 Human
immunosenescence: the prevailing of innate immunity, the failing of
clonotypic immunity, and the filling of immunological space. Vaccine
18: 1717–1720
26. PAOLISSO G, BARBIERI M, BONAFE M, FRANCESCHI C
2000 Metabolic age modelling: the lesson from centenarians. Eur J
Clin Invest 30: 888–894
27. BARBIERI M, RIZZO M R, MANZELL D, GRELLA R, RAGNO
E, CARBONELLA M, ABBATECOLA A M, PAOLISSO G 2003
Glucose regulation and oxidative stress in healthy centenarians. Exp
Gerontol 38: 137–143
28. BAUER M E 2005 Stress, glucocorticoids and ageing of the immune
system. Stress 8(1): 69–83
29. FRANCESCHI C, CAPRI M, MONTI D, GIUNTA S, OLIVIERI
F, SEVINI F, PANOURGIA M P, INVIDIA L, CELANI L, SCUR-
TI M, CEVENINI E, CASTELLANI G C, SALVIOLI S 2007
Inflammaging and anti-inflammaging: A systemic perspective on
aging and longevity emerged from studies in humans. Mech Age Dev
128: 92–105
30. SEN C K, PACKER L 1996 Antioxidant and redox regulation of
gene transcription. Faseb J 10: 709–20
31. KRIETE A, SOKHANSANJ B A, COPPOK D L, WEST G B 2006
Systems approaches to the network of aging: Review. Age Res 5:
434–448
32. JAENISCH R, BIRD A 2003 Epigenetic regulation of gene ex-
pression: how the genome integrates intrinsic and environmental
signals. Nat Genetics (suppl) 33: 244–254
33. SCHROECKSNADEL K, FRICK B, WIRLEITNER B, WIN-
KLER C, SCHENNACH H, FUCH D 2004 Moderate hyperho-
mocysteinemia and immune activation. Curr Pharmaceut Biotechnol
5: 107–118
34. McCLEARN G E 1997 Biomarkers of age and aging. Exp Gerontol
32: 87–94
35. MANTON K G 1999. Dynamic paradigms for human mortality
and aging. The Journals of Gerontol 54: 247–254
36. ROSSOLINI G, PIANTANELLI L 2001 Mathematical modeling
of the aging processes and the mechanisms of mortality: paramount
role of heterogeneity. Exp Gerontol 36: 1277–1288
37. PIANTANELLI L, ROSSOLINI G, BASSO A, PIANTANELLI
A, MALAVOLTA M, ZAIA A 2001 Use of mathematical models of
survivorship in the study of biomarkers of aging: the role of hetero-
geneity. Mech Age Dev 122: 1461–1475
38. COFFEY D S 1998 Self–organization, complexity and chaos, the
new biology for medicine. Nat Med 4(8): 882–885
39. GOLDBERGER A L 1996. Non-linear dynamics for clinicians:
chaos theory, fractals and complexity at the bedside. Lancet 347:
1312–1314
40. KITANO H 2002 Systems biology: A brief overview. Science 295
(5560): 1662–1664
41. FRIBOULET A, THOMAS D 2005 Systems biology – an inter-
disciplinary approach. Biosensors and bioelectronics 20: 2404–2407
42. LIPSITZ L A 2002 Dynamics of stability: the physiologic basis of
functional health and frailty. J Gerontol 57A(3): 115–125
43. PERLS T, LEVENSON R, REGAN M, PUCA A 2002 What does it
take to live to 100? Mech Age Dev 123: 231–242
44. KUSHNIRUK A W 2001 Analysis of complex decision-making
processes in health care: cognitive approaches to health informatics.
J of biomed informatics 34: 365–376
50 Period biol, Vol 110, No 1, 2008.
Ljiljana Majnari}-Trtica et al. Cardiovascular risk assessment
